Live
Home·Deals·Biotechnology·Johnson & Johnson Services Inc acquires Halda Therapeutics
Johnson & Johnson Services Inc acquires Halda Therapeutics (2026)
SEO URLwww.firestrike.ai/deals/halda-therapeutics-johnson-johnson-services-inc-acquisition-2026
acquisitionAnnounced · Jan 8, 2026BiotechnologySource · MagazinesArticle · Factual
Halda Therapeutics
Johnson & Johnson Services Inc
Halda Therapeutics · Johnson & Johnson Services Inc

Johnson & Johnson Services Inc acquires Halda Therapeutics

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$3.05B
Target
Halda Therapeutics
Halda Therapeutics
New Haven, Connecticut
Acquirer
Johnson & Johnson Services Inc
Johnson & Johnson Services Inc
Full Acquisition
Status
Pending

Johnson & Johnson Services Inc agreed to acquire Halda Therapeutics. Reported deal value: $3.05B. Status: Pending. Sector: Biotechnology. Target headquarters context: New Haven, Connecticut, United States.

This page summarizes publicly available information about the transaction as of 2026-01-08. Figures and status may change as filings and press coverage update.

Or on LinkedIn J&J Completes $3 - Bn Acquisition of Halda Therapeutics Johnson & Johnson has completed its $3 .05- billion acquisition of Halda Therapeutics , a clinical-stage bio/pharmaceutical company focused on oral therapies for multiple types of solid tumors, including prostate cancer

Deal timeline

Announced
Jan 8, 2026 · dcatvci.org
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biotechnology with a reported deal value of $3.05B. Figures and status may change as sources update.

Sources: dcatvci.org · Primary article · FireStrike proprietary index